Open Access
CC BY 4.0 · Indian Journal of Neurosurgery 2025; 14(02): 126-133
DOI: 10.1055/s-0044-1801829
Original Article

Efficacy of CyberKnife Stereotactic Radiosurgery in Treating Trigeminal Neuralgia: A Single-Institution Study

1   Saroj Gupta Cancer Centre and Research Institute, Kolkata, India
,
Mahadev Potharaju
2   Department of Radiation Oncology, Apollo Cancer Institute, Chennai, Tamil Nadu, India
,
Sanjay Chandrasekar
2   Department of Radiation Oncology, Apollo Cancer Institute, Chennai, Tamil Nadu, India
,
Balamurugan Mangaleswaran
3   Department of Neurosurgery, Apollo Cancer Institute, Chennai, Tamil Nadu, India
› Author Affiliations
Preview

Abstract

Introduction

Trigeminal neuralgia (TN) is a chronic facial pain disorder. While medications like analgesics and antiepileptics are first-line treatments, some patients may require surgical options like microvascular decompression or rhizotomies, which carry neurological risks. CyberKnife frameless stereotactic radiosurgery (CK SRS) offers a noninvasive, effective alternative with fewer side effects.

Methods and Materials

In our study, 30 patients with unilateral TN (VAS [visual analog scale] score > 5) were treated. Using computed tomography and magnetic resonance imaging, a 5 to 6 mm segment of the trigeminal nerve, located 2 to 3 mm distal to the brainstem's dorsal root entry zone, was targeted. A 60 Gy dose, prescribed to a median isodose of 85%, was delivered for radiosurgical rhizotomy.

Results

Patients were followed for a median of 48 months. Of the 30 patients, 21 achieved satisfactory pain relief (VAS ≤ 3), with pain relief occurring at varying intervals, and 9 patients had partial relief (VAS > 3) and remained on medication. One patient had a recurrence pain and was re-irradiated at 36 months. Ten patients developed facial numbness, assessed using the Barrow Neurological Institute Facial Numbness Scale score, with a latency period of 10 months. All patients were on carbamazepine, gabapentin, and mecobalamin until pain relief was achieved.

Conclusion

The nearly 70% success rate after SRS is comparable to or better than other treatment modalities for TN. Nonisocentric CyberKnife SRS proves to be a safe and effective option for managing TN.

Supplementary Material



Publication History

Article published online:
02 April 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India